- Price must be right to list GLP-1s Australian Journal of Pharmacy
- New obesity medicines recommended to reduce heart disease risk in new clinical consensus statement Heart Foundation
- Experts push for subsidised weight loss drugs to prevent heart attacks 7NEWS
- ‘Huge step forward’: Ozempic endorsed to treat obesity and heart disease in Australian first SBS Australia
- ‘Critical role’ of GLP-1s addressed in Australian-first obesity consensus Royal Australian College of General Practitioners (RACGP)